Creating a Global Company

EBITDA Trend In Rs Billion Sales 303 261 287 % of Sales 323 332 26.9% 28.0% 27.4% 28.6% 26.1% 16.2% 21.0% 20.8% 20.6% 19.7% 27.9% 28.5% 31.0% 31.1% 31.8% 29.0% 19.9% 20.7% 24.8% 20.0% FY17 FY18 FY19 FY20 FY21 EBITDA Other Expenditure Personnel Costs Material Costs SUN PHARMA 47

View entire presentation